ライフサイエンスコーパス: sodium-iodide symporter

1 sed expression of thyroglobulin (Tg) and the sodium/iodide symporter).

2 virus type I thymidine kinase and the human sodium-iodide symporter.

3 yroid-stimulating hormone in stimulating the sodium-iodide symporter.

4 as attributed to decreased expression of the sodium-iodide symporter.

5 egulated expression of thyroglobulin and the sodium/iodide symporter.

6 9m)technetium pertechnetate (mediated by the sodium-iodide symporter), (99m)technetium sestamibi (car

7 receptor expressing cells also expressed the sodium iodide symporter and thyroglobulin genes.

8 y antagonists increase the expression of the sodium-iodide symporter and uptake of iodine.

9 A levels for thyroglobulin, thyroperoxidase, sodium iodide symporter, and deiodinase type 2, and deio

10 tinib, which modulates the expression of the sodium iodide symporter, and hence iodine uptake, in the

11 2, sodium hydrogen exchanger 3, aquaporin 7, sodium iodide symporter, and hydrogen potassium adenosin

12 HR expression was required for expression of sodium-iodide symporter but was not required for thyrogl

13 Sodium iodide symporter expression in patient tumors aft

14 this observation was the lack of detectable sodium-iodide symporter expression in TSHR-KO thyroid gl

15 MV engineered to express the sodium iodide symporter gene (MV-NIS) facilitates locali

16 profound inhibition of the expression of the sodium iodide symporter gene.

17 The rat sodium/iodide symporter gene (rNIS) was cloned into a re

18 ted with a vaccinia virus carrying the human sodium iodide symporter GLV-1h153.

19 We incorporated the human sodium iodide symporter (hNIS) and the human somatostati

20 differentiation, including the loss of human sodium iodide symporter (hNIS) expression, radioactive i

21 carcinoembryonic antigen (CEA) or the human sodium iodide symporter (hNIS) for oncolytic potential i

22 ionuclide accumulation mediated by the human sodium iodide symporter (hNIS) gene in conjunction with

23 ntification of cardiac gene expression after sodium iodide symporter (hNIS) gene transfer in cardiac

24 ic vaccinia virus, GLV-1h153, carrying human sodium iodide symporter (hNIS), in combination with radi

25 Anion transport by the human sodium-iodide symporter (hNIS) is an established target

26 man norepinephrine transporter (hNET), human sodium-iodide symporter (hNIS), a human deoxycytidine ki

27 novel PET radioligand for imaging the human sodium/iodide symporter (hNIS).

28 BLI and sodium-iodide symporter imaging may be useful for in viv

29 Here we show that a specialized form of the sodium/iodide symporter in the mammary gland mediates ac

30 nal obtained by firefly luciferase and human sodium-iodide symporter labeling of cardiosphere-derived

31 hese results indicate that the mammary gland sodium/iodide symporter may be an essential breast cance

32 The sodium/iodide symporter mediates active iodide transport

33 pression of TTF1 increased thyroglobulin and sodium/iodide symporter mRNA levels, cell migration, and

34 virus (VSV)-murine interferon beta (IFNbeta)-sodium iodide symporter (NIS) (VSV-mIFNbeta-NIS) oncolyt

35 second strategy involves transduction of the sodium iodide symporter (NIS) and free radionuclide ther

36 cells with retroviral vectors containing the sodium iodide symporter (NIS) and thyroperoxidase (TPO)

37 aft breast cancer model expressing the human sodium iodide symporter (NIS) as a reporter.

38 The application of sodium iodide symporter (NIS) as a theranostic gene allo

39 In the current study, we used the sodium iodide symporter (NIS) as a theranostic gene to i

40 cancer cells to express functionally active sodium iodide symporter (NIS) by targeted NIS gene trans

41 ast cancer cells stably expressing the human sodium iodide symporter (NIS) fused to a red fluorescent

42 n the matrix protein and expresses the human sodium iodide symporter (NIS) gene.

43 The sodium iodide symporter (NIS) is required for iodide upt

44 The sodium iodide symporter (NIS) is widely used as a report

45 The sodium iodide symporter (NIS) mediates iodide uptake int

46 its binding factor PBF repress expression of sodium iodide symporter (NIS) messenger RNA (mRNA), and

47 In this study, sodium iodide symporter (NIS) transgene imaging was eval

48 cancer cells to express functionally active sodium iodide symporter (NIS) would enable those cells t

49 din-Darby canine kidney cells expressing the sodium iodide symporter (NIS), pendrin, or NIS and pendr

50 ne levels by up-regulating expression of the sodium iodide symporter (NIS), thyroid peroxidase (TPO),

51 T tracer with excellent properties for human sodium iodide symporter (NIS)-based imaging in patients

52 is one of the most promising candidates for sodium iodide symporter (NIS)-mediated gene therapy.

53 f therapeutic genes, such as the theranostic sodium iodide symporter (NIS).

54 and polymerase chain reaction for gal-3 and sodium-iodide symporter (NIS) expression.

55 We examined the sodium-iodide symporter (NIS), which promotes in vivo ce

56 h uptake into thyroid tissue mediated by the sodium-iodide symporter (NIS).

57 t tissue and some breast cancers express the sodium/iodide symporter (NIS) and concentrate iodide.

58 The sodium/iodide symporter (NIS) concentrates iodide in the

59 The sodium/iodide symporter (NIS) has been identified as an

60 Perchlorate, thiocyanate, and nitrate are sodium/iodide symporter (NIS) inhibitors that block iodi

61 The sodium/iodide symporter (NIS) is the essential plasma me

62 The sodium/iodide symporter (NIS) is under investigation as

63 The sodium/iodide symporter (NIS) mediates active I(-) trans

64 The sodium/iodide symporter (NIS) mediates active iodide (I(

65 sitron emission tomography imaging using the sodium/iodide symporter (NIS) reporter gene revealed sta

66 The sodium/iodide symporter (NIS) stimulates iodide uptake i

67 ds to the 3'-untranslated region of PAX8 and sodium/iodide symporter (NIS), leading to impaired prote

68 wn that RET/PTC1 decreases expression of the sodium/iodide symporter (NIS), the molecule that mediate

69 se model of hypothyroidism: mice lacking the sodium/iodide symporter (NIS), the plasma membrane prote

70 in the thyroid and breast is mediated by the sodium/iodide symporter (NIS).

71 functional role in tumor progression of the sodium/iodide symporter (NIS; aka SLC5A5), which is upre

72 isease, based on decreased expression of the sodium iodide symporter SLC5A5 (NIS), diminished membran

73 Pax-8, thereby suppressing expression of the sodium iodide symporter, thyroid peroxidase, TG, and thy

74 thyroid-specific target genes thyroglobulin, sodium iodide symporter, thyroperoxidase, and thyroid-st

75 ansmembrane receptor Smoothened, and 13-pass Sodium-iodide symporter to extracellular vesicles (EVs)

76 mputed tomography imaging of the hNIS (human sodium/iodide symporter) to noninvasively quantify adeno

77 the hormonal regulation of the mammary gland sodium/iodide symporter, we demonstrate by scintigraphy